Home > Compound List > Product Information
4-Aminoindole_Molecular_structure_CAS_5192-23-4)
Click picture or here to close

4-Aminoindole

Catalog No. 08244 Name Sigma Aldrich
CAS Number 5192-23-4 Website http://www.sigmaaldrich.com
M. F. C8H8N2 Telephone 1-800-521-8956
M. W. 132.16252 Fax
Purity ≥98.0% (NT) Email
Storage Chembase ID: 10442

SYNONYMS

Title
4-氨基吲哚
IUPAC name
1H-indol-4-amine
IUPAC Traditional name
1H-indol-4-amine
Synonyms
4-Indolamine
4-吲哚胺
(Indol-4-yl)amine

DATABASE IDS

CAS Number 5192-23-4
Beilstein Number 114919
MDL Number MFCD01076559
PubChem SID 24846037

PROPERTIES

Empirical Formula (Hill Notation) C8H8N2
Grade purum
Purity ≥98.0% (NT)
Melting Point 106-109 °C(lit.)
Melting Point 107-111 °C
GHS Pictograms GHS07
GHS Signal Word Warning
GHS Hazard statements H315-H319-H335
European Hazard Symbols Irritant Irritant (Xi)
MSDS Link Download
Personal Protective Equipment dust mask type N95 (US), Eyeshields, Gloves
GHS Precautionary statements P261-P305 + P351 + P338
Risk Statements 36/37/38
Safety Statements 26-36
Storage Temperature -20°C
German water hazard class 3

DETAILS

Description (English)
Application
Reactant for preparation of:
• Inhibitors of bacterial thymidylate synthase1
• Mimetics of non-alkaloid toxin lignan anticancer and antiviral agent Podophyllotoxin (PPT)2
• Inhibitors of Gli1-mediated transcription in the Hedgehog pathway3
• Protein kinase C θ (PKCθ) inhibitors4
• Indolic non-peptidic HIV protease inhibitors5
• Transient receptor potential cation channel subfamily V member 1 (TRPV1) antagonists6
• Cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors7
• 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) inhibitors8
• Short chain 4-substituted indoles as potent αvβ3 antagonist9
• Ligands of serotonin transporter and 5-HT1A receptors10
Description (简体中文)
Application
Reactant for preparation of:
• Inhibitors of bacterial thymidylate synthase1
• Mimetics of non-alkaloid toxin lignan anticancer and antiviral agent Podophyllotoxin (PPT)2
• Inhibitors of Gli1-mediated transcription in the Hedgehog pathway3
• Protein kinase C θ (PKCθ) inhibitors4
• Indolic non-peptidic HIV protease inhibitors5
• Transient receptor potential cation channel subfamily V member 1 (TRPV1) antagonists6
• Cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors7
• 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) inhibitors8
• Short chain 4-substituted indoles as potent αvβ3 antagonist9
• Ligands of serotonin transporter and 5-HT1A receptors10

REFERENCES